Article
Sun Pharmaceutical Industries, based in India, will acquire DUSA Pharmaceuticals, aiming to advance into the dermatologic market in the United States.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.